Ew Healthcare Partners Fund 2, L.P.'s Form 4 filing
TELA Bio, Inc. (TELA) · filed Nov 17, 2025
- Accession no.
- 0000908834-25-000358
- Filed
- Nov 17, 2025, 4:26 PM ET
- Trade date
- Nov 17, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $4.00M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ew Healthcare Partners Fund 2, L.P.CIK 0001746777 | 10% Owner, Other: See Remarks |
| Ew Healthcare Partners Fund 2-A, L.P.CIK 0001746779 | 10% Owner, Other: See Remarks |
| EW Healthcare Partners Fund 2 GP, L.P.CIK 0001793943 | 10% Owner, Other: See Remarks |
| EW Healthcare Partners Fund 2-UGP, LLCCIK 0001793948 | 10% Owner, Other: See Remarks |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +3,604,000 | $1.11 | +$4,000,440 | 7,714,709 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The amount reported in Column 5 of Table I reflects the aggregate number of shares of the Issuer's common stock (the "Shares") held by the Reporting Persons as of the date of this filing. As of such date, the Reporting Persons hold an aggregate 7,714,709 Shares, 3,031,617 of which are held by EW Healthcare Partners Fund 2, L.P. ("EW Fund 2") and 4,683,092 of which are held by EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A," and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-GP, L.P. ("EW Funds GP") is the general partner of each of the EW Funds. EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the Shares. The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares held by the EW Funds only by majority action of the Managers. Each of the Managers, EW Funds GP and the General Partner disclaims ownership over the Shares held by the EW Funds except to the extent of his or its respective pecuniary interest therein.